Jeanne F. Loring

A role for stem cell biology in the physiological and pathological aspects of aging.

Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis.

Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.

Evolution of microarray analysis.

Establishing standards for the characterization of human embryonic stem cell lines.

Assessing self-renewal and differentiation in human embryonic stem cell lines.

NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells.

Gene therapy: can neural stem cells deliver?

Beyond fraud--stem-cell research continues.

Science and law. Intellectual property and human embryonic stem cell research.

Transcriptome coexpression map of human embryonic stem cells.

Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines.

Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells.

Human embryonic stem cells have a unique epigenetic signature.

Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins.

Unraveling epigenetic regulation in embryonic stem cells.

Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence.

The ACTCellerate initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives.

Differentiation of neural lineage cells from human pluripotent stem cells.

Regulatory networks define phenotypic classes of human stem cell lines.

Preparation of autogenic human feeder cells for growth of human embryonic stem cells.

Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency.

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

DNA methylation in embryonic stem cells.

Restricted ethnic diversity in human embryonic stem cell lines.

Propagation of human embryonic and induced pluripotent stem cells in an indirect co-culture system.

A modest proposal in response to Rhodes and Schiano.

A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells.

A call to standardize teratoma assays used to define human pluripotent cell lines.

Growth of an industry: how U.S. scientists and clinicians have enabled stem cell tourism.

Friedreich's ataxia induced pluripotent stem cells model intergenerational GAAâ‹…TTC triplet repeat instability.

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells.

A bioinformatic assay for pluripotency in human cells.

A call for standardized naming and reporting of human ESC and iPSC lines.

Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs.

Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus.

Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy.

Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state.

Induced pluripotent stem cells from highly endangered species.

Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis.

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.